 MELBOURNE, Australia, Dec. 12, 2022 GLOBE NEWSWIRE -- Opthea Limited ASX:OPT; NASDAQ:OPT, a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announce that MST Access will host an Ask the Expert conference call with Professor Jason S. Slakter, M.D. on Tuesday 13th December 6:30pm 7:30pm EST USA Wednesday 14th December 10:30am 11:30am AEDT. 